Hiccups and severe hyponatremia associated with high-dose cyclophosphamide in conditioning regimen for allogeneic stem cell transplantation

被引：9
|
作者：
Lazarevic, V. [1 ]
Hagg, E.
Wahlin, A.
机构：
[1] Univ Hosp No Sweden, Dept Hematol, SE-90185 Umea, Sweden
[2] Univ Hosp No Sweden, Dept Internal Med, SE-90185 Umea, Sweden
来源：
AMERICAN JOURNAL OF HEMATOLOGY | 2007年 / 82卷 / 01期
关键词：
D O I：
10.1002/ajh.20706
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：88 / 88
页数：1
相关论文
共 50 条
  • [21] Thiotepa/cyclophosphamide/TBI as a conditioning regimen for allogeneic hematopoietic stem cell transplantation in patients with myelodysplastic syndrome
    K Fujimaki
    J Taguchi
    H Fujita
    M Hattori
    E Yamazaki
    N Takahashi
    S Fujisawa
    H Kanamori
    A Maruta
    Y Ishigatsubo
    Bone Marrow Transplantation, 2004, 33 : 789 - 792
  • [22] Nonmyeloablative conditioning and allogeneic stem cell transplantation as consolidation therapy after high-dose melphalan and autologous stem cell transplantation for multiple myeloma
    Schneider, P
    Fenk, R
    Bernhard, A
    Huenerlituerkoglu, AN
    Aivado, M
    Wehmeier, A
    Pape, H
    Haas, R
    Kobbe, G
    BONE MARROW TRANSPLANTATION, 2002, 29 : S101 - S101
  • [23] HIGH-DOSE BUSULFAN (BU) AND CYCLOPHOSPHAMIDE (CY) AS CONDITIONING REGIMEN IN BONE-MARROW TRANSPLANTATION (BMT)
    QUABECK, K
    BEELEN, DW
    SAYER, H
    GRAEVEN, U
    SCHAEFER, UW
    SCHMIDT, CG
    BLUT, 1987, 55 (04): : 374 - 374
  • [24] High-dose treosulfan in conditioning prior to hematopoietic stem cell transplantation
    Glowka, Franciszek K.
    Romanski, Michal
    Wachowiak, Jacek
    EXPERT OPINION ON INVESTIGATIONAL DRUGS, 2010, 19 (10) : 1275 - 1295
  • [25] HIGH-DOSE BUSULFAN AND MELPHALAN AS CONDITIONING REGIMEN PRIOR TO TRANSPLANTATION
    MARIT, G
    CONY, P
    DAVID, B
    BROUSTET, A
    REIFFERS, J
    BONE MARROW TRANSPLANTATION, 1988, 3 : 78 - 78
  • [26] Autologous hematopoietic stem cell transplantation in severe multiple sclerosis. The Brazilian experience with two conditioning regimes: BEAM and high-dose cyclophosphamide
    Voltarelli, Julio C.
    Coutinho, Marina A.
    Stracieri, Ana Beatriz P. L.
    Oliveira, Maria Carolina B.
    Moraes, Daniela A.
    Pieroni, Fabiano
    Simoes, Belinda P.
    Barros, George M. N.
    Ribeiro, Amilton F.
    Hamerschlak, Nelson
    Leite, Cesar
    Zanis, Jose
    BLOOD, 2007, 110 (11) : 848A - 848A
  • [27] Intensified myeloablative conditioning with TBI, cyclophosphamide and G-CSF-combined high-dose cytarabine in allogeneic haematopoietic stem cell transplantation for myeloid malignancies
    Mori, T.
    Kato, J.
    Yamane, A.
    Koda, Y.
    Okamoto, S.
    BONE MARROW TRANSPLANTATION, 2013, 48 : S238 - S238
  • [28] Modified conditioning regimen busulfan-cyclophosphamide followed by allogeneic stem cell transplantation in patients with multiple myeloma
    (Zhang XH
    中华医学杂志(英文版), 2007, (06) : 463 - 468
  • [29] Once daily intravenous busulfan as part of a busulfan/cyclophosphamide conditioning regimen for allogeneic hematopoietic stem cell transplantation
    Mates, M
    Michalska, H
    Hasegawa, W
    Kiss, T
    Daly, A
    Loach, D
    Messner, H
    Lipton, J
    BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION, 2004, 10 (02) : 36 - 36
  • [30] Modified conditioning regimen busulfan-cyclophosphamide followed by allogeneic stem cell transplantation in patients with multiple myeloma
    Zhang XHHuang XJLiu KYXu LPLiu DHChen HChen YHWang JZHan W and Lu DPInstitute of HematologyPeking University Peoples HospitalBeijing China
    ChineseMedicalJournal, 2007, 120 (06) : 463 - 468
12345